Cargando…

Skeletal Muscle Health in Polycystic Ovary Syndrome: Protective Effect of Hyperandrogenism or Detrimental Effect of Insulin Resistance? A Systematic Review and Meta-Analysis

Women with polycystic ovary syndrome (PCOS) exhibit reduced skeletal muscle insulin-mediated glucose uptake. Altered muscle mass may affect insulin resistance (IR) and inflammation, thereby potentially aggravating reproductive status including ovulatory cyclicity and fertility potential. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazemi, Maryam, Pierson, Roger A, Parry, Stephen A, Kaviani, Mojtaba, Chilibeck, Philip D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266181/ http://dx.doi.org/10.1210/jendso/bvab048.1514

Ejemplares similares

OR31-01 A Randomized Controlled Trial of a Lifestyle Intervention with Longitudinal Follow up on Ovarian Dysmorphology, Hyperandrogenism, and Menstrual Irregularity in Women with Polycystic Ovary Syndrome
por: Kazemi, Maryam, et al.
Publicado: (2020)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

THU632 Musculoskeletal Composition And Function In Polycystic Ovary Syndrome: Early Evidence From A Prospective Study
por: Kazemi, Maryam, et al.
Publicado: (2023)

PMON244 Alterations in Nonesterified Free Fatty Acids (NEFA) Trafficking Rather Than Hyperandrogenism Contribute to Variations in Insulin Sensitivity Among Obese Women with Polycystic Ovary Syndrome
por: Azziz, Ricardo, et al.
Publicado: (2022)

SAT-023 Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study
por: Kazemi, Maryam, et al.
Publicado: (2020)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

Post Menopausal Hyperandrogenism: A Case of a Steroid Cell Tumor of the Ovary
por: Hassan Nelson, Lauren Juliette, et al.
Publicado: (2021)

THU643 Hyperandrogenism Caused By A Steroid Cell Tumor Of The Ovary In A Postmenopausal Woman
por: Mon Myint, Myat Su, et al.
Publicado: (2023)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model
por: Chen, Yen-Hao, et al.
Publicado: (2023)

PMON220 Women With Polycystic Ovary Syndrome Have Worse Lifestyle Behaviors Compared to Controls: A Systematic Review and Meta-Analysis of 36,360 Women
por: Ganga, Kiran, et al.
Publicado: (2022)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

PMON219 Disparities in Musculoskeletal Health Profiles Across Race and Ethnicity in United States-Based Women with Polycystic Ovary Syndrome per the 2018 International Guideline
por: Kazemi, Maryam, et al.
Publicado: (2022)

MON-002 The Effect of GNRHR Autoantibody on Reproduction Function and Insulin Signaling Intermediates in a New Animal Model of Polycystic Ovary Syndrome
por: Li, Hongliang, et al.
Publicado: (2020)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

Genetic Sex Effects of Polycystic Ovary Syndrome Reveal Distinct Metabolic Etiology
por: Actkins, Ky’Era, et al.
Publicado: (2021)

SUN-020 Waist Circumference Is Associated with Insulin Resistance in Young Korean Women with Polycystic Ovary Syndrome
por: Song, Do Kyeong, et al.
Publicado: (2020)

Ethnic Disparities in Cardio-Metabolic and Reproductive Profiles in Women With Polycystic Ovary Syndrome per the New International Guideline: A United-States Based Multi-Center Study
por: Kazemi, Maryam, et al.
Publicado: (2021)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

Ovarian Hyperthecosis: Hyperandrogenism in a Post-Menopausal Woman
por: Fayad, Christine, et al.
Publicado: (2021)

THU637 The Effects Of Polyphenol On Insulin Resistance And Hormonal Parameters On Women With Polycystic Ovary Syndrome: A Systematic Review And Meta-analysis Of Randomized Controlled Trials
por: Almeida Balieiro, Caroline Cristine, et al.
Publicado: (2023)

MON-LB038 Reduced Exercise Endurance And Skeletal Muscle Alterations In A Prenatally Androgenized Rat Model For Polycystic Ovary Syndrome
por: DeChick, Auryana, et al.
Publicado: (2019)

The Association Between Clinical and Biochemical Hyperandrogenism in Women With Female Pattern Hair Loss
por: Odhaib, Samih A, et al.
Publicado: (2021)

OR35-03 Uncovering Causative Mutations in Polycystic Ovary Syndrome
por: Srivastava, Jaya, et al.
Publicado: (2023)

FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
por: Husby, Anne Engtrø, et al.
Publicado: (2023)

FRI426 Raised Thyroid Stimulating Hormone In Girls With Polycystic Ovary SyndromeEffects Of Randomized Interventions
por: Ibanez, Lourdes, et al.
Publicado: (2023)

THU646 Postmenopausal Hyperandrogenism Secondary To Ovarian Leydig Cell Tumor
por: Batch, Jennifer Tania, et al.
Publicado: (2023)

SAT364 A Rare Cause of Hyperandrogenism in a Premenopausal Woman
por: Musa Penna, Laurianne El, et al.
Publicado: (2023)

ODP642 Differences in hormonal profiles and vitamin D status depending on the insulin sensitivity status in women with polycystic ovary syndrome (PCOS).
por: Ozga-Piszczek, Katarzyna, et al.
Publicado: (2022)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

FRI457 Protein-coding Genetic Variation In Polycystic Ovary Syndrome
por: Parker, Chloe, et al.
Publicado: (2023)

OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk
por: Ollila, Meri-Maija, et al.
Publicado: (2023)

MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
por: folawewo, kehinde Matilda, et al.
Publicado: (2020)

SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
por: Chavez, Luis, et al.
Publicado: (2019)

A Case of Hyperreactio Luteinalis Complicated With Biochemical Hyperandrogenism, Symptomatic Hyperthyroidism and Preeclampsia
por: Wong, K Y, et al.
Publicado: (2021)

OR04-04 Sexually Dimorphic Impact Of Gestational Hyperandrogenism On Offspring Growth Trajectory
por: Topaktas, Eylem, et al.
Publicado: (2023)

SAT376 Luteinizing Hormone Secretion in Hyperandrogenic Girls Taking Spironolactone or Metformin
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2023)

THU628 Causal Relationship Between The Menstrual Cycle Length And Basal Metabolic Rate: A Two-sample Mendelian Randomization Study
por: Kazemi, Maryam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5jjen1pmrgu72nljsbpvnarn59